简体
简体中文
繁體中文

FTI咨询 FCN

等待开盘 09-24 09:30:00 美东时间

133.49

-1.210

-0.90%

华盛通华盛通
立即下载
  • 最 高136.00
  • 今 开133.84
  • 成交量 54.24万股
  • 最 低 132.59
  • 昨 收 134.70
  • 总市值 36.86亿
  • 52周最高 189.30
  • 市盈率 16.20
  • 换手率 1.96%
  • 52周最低 132.59
  • 委 比 -84.62%
  • 总股本 2761.16万
  • 历史最高 243.60
  • 量 比 0.84
  • 振 幅 2.53%
  • 历史最低 22.88
  • 每 手 1
  • 风险率 10.88%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Q1 2026 Dividend Exchange Rate - Corrected

    Diversified Energy Company announced on May 6, 2026, a Q1 2026 Dividend of 29 cents per share, payable on September 30, 2026, to shareholders registered on August 28, 2026. Shareholders opting for GBP payments will receive 21.396 pence per share, based on the September 10, 2026 exchange rate of GBP 0.73781 = US $1.00. For more information, contact Doug Kris at Diversified Energy Company or FTI Consulting.

    09-17 06:00

  • EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    EyePoint, Inc. granted non-statutory stock options to a new employee outside its 2023 Long-Term Incentive Plan, totaling 3,000 shares, under NASDAQ Listing Rule 5635(c)(4). The options, exercisable at $3.66 per share, vest over four years with 25% on the first anniversary and the remainder in monthly installments. EyePoint, a biopharmaceutical company, is developing DURAVYU™, an investigational treatment for retinal diseases, currently in Phase 3...

    09-16 11:00

  • Q1 2026 Dividend Exchange Rate

    Diversified Energy Company announced a Q1 2026 dividend of 29 cents per share, payable on September 30, 2026, to shareholders registered as of August 28, 2026. Shareholders opting for GBP payments will receive 21.567 pence per share, based on the September 10, 2026 exchange rate of GBP 0.73781 = US $1.00. The company focuses on acquiring and optimizing energy assets sustainably, generating reliable cash flow and shareholder value.

    09-16 06:00

  • Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

    Senseonics and Beta Bionics collaborate to integrate Eversense 365 CGM with iLet Bionic Pancreas for enhanced diabetes management. The combined system aims to simplify insulin delivery and glucose monitoring, offering a year-long sensing solution without carb counting. Commercial launch planned for Q4 2026.

    09-14 11:00

  • Diversified Announces Accretive Acquisition of Birch

    Diversified Energy Company announced the acquisition of Birch Permian Holdings, Inc. for $1.8 billion, expanding its Permian Basin operations and increasing production by ~35% and Adjusted EBITDA by ~55%. The deal enhances Diversified's position as a premier Permian operator, with Birch's high-quality, low-decline assets and integrated infrastructure. Carlyle will support the transaction through an $1.5 billion ABS, and the partnership will expan...

    09-02 23:26

  • EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting

    EyePoint, Inc. will participate in several upcoming conferences, including the Citi 2026 Biopharma Back to School Conference on September 9, 2026, the Cantor Global Healthcare Conference 2026 on September 10, 2026, and the Morgan Stanley Global Healthcare Conference on September 15, 2026. Fireside chats from these events will be available on the Company’s website. Additionally, EyePoint will present at The Retina Society 59th Annual Scientific Me...

    09-02 11:00

  • Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

    Skye Bioscience and Redx Pharma have entered into a definitive transaction agreement to merge, forming Fibrx Therapeutics, a fibrosis-focused company. The combined entity will trade on Nasdaq and is backed by $125 million in financing, aiming to fund operations through 2029. Fibrx’s lead program, RXC008, a GI-restricted pan-ROCK inhibitor for fibrostenotic Crohn’s disease, is set to begin a Phase 2 clinical trial with topline data expected in H2 ...

    08-14 13:33

  • Diversified Energy Response to Media Speculation

    Diversified Energy Company (DEC) addresses recent media speculation about a potential transaction, confirming preliminary discussions regarding the possible acquisition of Birch Resources. While no agreement has been reached, the company emphasizes its disciplined acquisition strategy, having completed 35 deals totaling over $7 billion since its 2017 IPO. The discussions remain at an early stage, and no certainty exists regarding a transaction or...

    08-14 06:00

  • PDMR Shareholdings

    Diversified Energy Company announces the vesting of restricted stock units awarded to David Johnson, former Chairman of the Board, on August 5, 2026. Johnson, a PDMR until his retirement, will receive 13,582 shares, increasing his holdings to 39,144 shares, representing 0.06% of the issued share capital.

    08-11 06:00

  • 财报速睇 | FTI咨询 2026财年Q2营收9.93亿美元,同比增长5.3%;归母净利润0.58亿美元,同比下滑19.4%

    华盛资讯8月1日讯,FTI咨询公布2026财年Q2业绩,公司Q2营收9.93亿美元,同比增长5.3%,归母净利润0.58亿美元,同比下滑19.4%。

    08-01 04:47